Hantz Financial Services’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$401K Sell
757
-194
-20% -$89.5K 0.01% 813
2026
Q1
$457K Buy
951
+207
+28% +$106K 0.01% 666
2025
Q4
$418K Buy
744
+217
+41% +$123K 0.01% 640
2025
Q3
$271K Buy
527
+320
+155% +$140K ﹤0.01% 666
2025
Q2
$65K Buy
207
+203
+5,075% +$60.9K ﹤0.01% 873
2025
Q1
$1K Buy
+4
New +$1.35K ﹤0.01% 1556

Other funds holding MEDP

Hantz Financial Services's MEDP Position: Q2 2026 in Review

Hantz Financial Services reduced its Medpace (MEDP) stake by 20% in Q2 2026, selling an estimated $89.5K and leaving 757 shares worth $401K. The position accounts for 0.01% of the portfolio, ranked #813.

Hantz Financial Services first reported a position in MEDP in Q1 2025 and has held it in 6 quarters since. The position peaked at $457K in Q1 2026. 697 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Hantz Financial Services held 757 shares of Medpace worth $401K as of Q2 2026.
  • Hantz Financial Services sold 194 Medpace shares in Q2 2026, an estimated $89.5K.
  • Medpace made up 0.01% of Hantz Financial Services's portfolio in Q2 2026, its #813 holding.
  • Hantz Financial Services first reported a position in Medpace in Q1 2025 and has held it in 6 quarters since.
  • Hantz Financial Services's Medpace position peaked at $457K in Q1 2026.
  • 697 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Hantz Financial Services's 13F filing for Q2 2026, filed 13 Aug 2026.